Apimeds Pharmaceuticals US, Inc. (AMEX:APUS) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of pIPE financing Closed: US$100M raised · E.F. Hutton & Co. Dealers: E.F. Hutton & Co. (lead) Use of proceeds: Ten percent of net proceeds to new subsidiary Newco, ninety percent to MindWave | May 5, 2026 |
| Public offering of shares of common stock Closed: US$13.5M raised · US$4 a share · D. Boral Capital LLC Dealers: D. Boral Capital LLC (lead) Use of proceeds: Phase III knee osteoarthritis trial, a multiple sclerosis sponsorship study, product manufacturing and general working capital | May 12, 2025 |